Cormorant Asset Management, LP - 31 Dec 2025 SCHEDULE 13G Report for MoonLake Immunotherapeutics Class A ordinary share, par value $0.0001 per share (MLTX)

Filing Manager: Cormorant Asset Management, LP
Reporting Manager: Cormorant Asset Management, LP
Security: MoonLake Immunotherapeutics Class A ordinary share, par value $0.0001 per share
Symbol: MLTX
Shares outstanding: 71,400,541 shares
Disclosed Ownership: 4,355,433 shares
Ownership: 6.1%
Form type: SCHEDULE 13G
Filing time: 17 Feb 2026, 15:01:28 UTC
Date of event: 31 Dec 2025
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Cormorant Asset Management, LP	6.1%	4,355,433	0	4,355,433	/s/ Bihua Chen	Bihua Chen, Managing Member
Bihua Chen	6.1%	4,355,433	0	4,355,433	/s/ Bihua Chen	Bihua Chen